Longevity and Anti-Senescence Therapy Market on Track to Reach $44.2 Billion by 2030

The global longevity and anti-senescence therapy market was valued at $25.1 billion in 2020, and is projected to reach $44.2 billion by 2030, growing at a CAGR of 6.1% from 2021 to 2030. Slowing the breakdown of skin and also stopping the development of age-related diseases are areas that have the broad impacts on human health and medicine. The anti-aging research has focused on understanding and finding ways to manipulate the metabolic pathways. Various approaches have been proposed to target cell senescence, either by inducing the death of senescent cells or by blocking the SASP.

♦ Download Sample PDF:
https://www.alliedmarketresearch.com/request-sample/14379

The main factors driving the growth of the longevity and anti-inflammatory drug market are the increasing prevalence of chronic diseases, the proliferation of anti-aging products, and advances in AI-focused medicine technology. In addition, the geriatric population is increasing and the rise for personalized treatment, precision, prevention and aging is driving the growth of the market. However, shortage of skilled professionals and inability to repair the tissue hinders the market growth during the forecast period. On the other hand, increased demand for cellular research and R&D is expected to provide growth opportunities for the market.

Major Key Market Players -

• Life Biosciences, Inc.,
• Oisin Biotechnologies,
• T.A. Sciences, Inc.,
• Unity Biotechnology, Inc.,
• CohBar, Inc.,
• Bristol-Myers Squibb Company,
• Pfizer Inc.,
• AgeX Therapeutics, Inc.,
• Merck & Co., Inc.,
• Calico Life Sciences LLC

Based on the treatment regimen, the longevity market is segmented into senolytic drug therapy, gene therapy, and immunotherapy. The gene therapy segment dominates the market in 2020 and is expected to be the dominant player during the forecast period, due to rise in awareness of longevity and vaccines, rise in disease and - not slow and effective product launch.

♦ For Purchase Inquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/14379

According to the application, longevity is divided into senescence treatment research such as cancer and others. The cancer segment dominates the market in 2020 and is expected to continue to dominate during the forecast period, due to the increase in anti-aging products and the increase in revenue.

According to the end user, the longevity market is divided into hospitals and healthcare facilities. Hospitals dominate the market in 2020 and is expected to continue during the forecast period, due to the extensive use of anti-aging products in hospitals for chronic diseases and advancements in technology medicine from AI.

Based on region, North America held the highest market share in terms of revenue in 2020, accounting for more than one-third of the global longevity and anti-senescence therapy market, and is projected to maintain its dominance in terms of revenue by 2030. This is due to surge in demand for anti-aging products, availability of advanced healthcare facilities with trained medical professionals, and presence of key market players. However, Asia-Pacific is projected to portray the fastest CAGR of 6.9% during the forecast period, owing to rise in demand for anti-aging products and availability of advanced healthcare facilities with trained medical professionals.

♦ Request For Customization:
https://www.alliedmarketresearch.com/request-for-customization/14379

Key Findings Of The Study -

♦ Depending on therapy, the gene therapy segment held majority share in the global longevity and anti-senescence therapy market forecast in 2020.
♦ Depending on application, the cancer segment held majority share in the global market in 2020.
♦ According to end user, the hospitals segment held majority share in the global market in 2020.
♦ Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.9% during the forecast period.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.